An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group.
about
Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boardsClinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs)Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
P2860
An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An update to returning genetic ...... harmacogenomics working group.
@ast
An update to returning genetic ...... harmacogenomics working group.
@en
type
label
An update to returning genetic ...... harmacogenomics working group.
@ast
An update to returning genetic ...... harmacogenomics working group.
@en
prefLabel
An update to returning genetic ...... harmacogenomics working group.
@ast
An update to returning genetic ...... harmacogenomics working group.
@en
P2093
P2860
P356
P1433
P1476
An update to returning genetic ...... harmacogenomics working group.
@en
P2093
David J Pulford
Joanne Malia
John E Brandt
Lea C Harty
Lester J Arnold
Sandra Gilardi
P2860
P356
10.1111/BIOE.12073
P577
2014-01-29T00:00:00Z